DataString Consulting Company Logo
DataString Consulting Company Logo
Sodium Sulfacetamide Market
Home»Top Market Reports»Sodium Sulfacetamide Market

Sodium Sulfacetamide Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1802106, Published - March 2025

Segmented in Product Form (Topical suspension, Topical cream, Topical gel), Application (Acne treatment, Seborrheic dermatitis management, Blepharitis therapy, Others), End-Use Industry, Distribution Channel, Regulatory Status and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Sodium Sulfacetamide Market Outlook

The market, for Sodium sulfacetamide was estimated at $518.0 million in 2024; and it is anticipated to increase to $883.1 million by 2030 with projections indicating a growth to around $1.4 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 9.3% over the forecast period. The thriving Sodium sulfacetamide market reflects the increasing demand and importance it holds across industries today. The primary factors propelling this growth include its effectiveness in treating a variety of skin conditions such as acne and rosacea. Moreover the versatility of Sodium sulfacetamide in a range of applications has underscored its continued relevance and value in the pharmaceutical sector. It is also worth noting that shifting healthcare trends and advancements in technology are paving the way for a future for this market thus enhancing its potential, for further expansion.


The use of sodium sulfacetamide as an antibacterial ingredient has become increasingly popular in dermatology due to its quick absorption and ability to inhibit bacterial growth effectively in various skin treatments such, as creams and cleansers used for a range of skin issues.


Market Size Forecast & Key Insights

2019
$517M2024
2029
$1.3B2034

Absolute Growth Opportunity = $742M

The Sodium Sulfacetamide market is projected to grow from $518.0 million in 2024 to $1.26 billion in 2034. This represents a CAGR of 9.3%, reflecting rising demand across Acne Treatment, Seborrhoeic Dermatitis Treatment and Rosacea Management.

The Sodium Sulfacetamide market is set to add $742 million between 2024 and 2034, with manufacturer targeting Seborrheic dermatitis management & Blepharitis therapy Application projected to gain a larger market share.

With Rise in acne prevalence, and Advancements in dermatological treatments, Sodium Sulfacetamide market to expand 143% between 2024 and 2034.

Opportunities in the Sodium Sulfacetamide Market

Expanding Use in Dermatology

Dermatologists around the world are increasingly acknowledging the advantages of Sodium sulfacetamide in addressing issues like acne and rosacea which are growing more common due to changes in lifestyle choices and habits. The use of Sodium sulfacetamide, in the field of dermatology is opening up an yet unexplored market.

Technological Enhancements in Drug Delivery and Strategic Partnerships to Positively Impact Distribution Chain

The emergence of technologies brings hopeful opportunities for the Sodium sulfacetamide industry sector with the development of advanced drug delivery methods that could boost the effectiveness of Sodium sulfacetamide by increasing its absorption rate and maximizing its positive effects on various skin conditions. These advancements in drug delivery systems are driving the growth prospects, for Sodium sulfacetamide in a way.

The market for Sodium sulfacetamide is set to gain from partnerships formed between companies and distributors collaborating strategically​​​. By leveraging the strengths of both sides through these partnerships​​​ Sodium sulfacetamide can reach an audience​​​ offering advanced treatments to a larger group of patients and expanding growth opportunities, for the market​​​.

Growth Opportunities in North America and Europe

Europe Outlook

In Europe's dermatological fields Sodium sulfacetamide is set to gain advantages from the significant rise in research activities and applications in the pharmaceutical industry. The emphasis is particularly placed in creating remedies for various skin problems. The growing awareness of cosmetics among customers and the popularity of Sodium sulfacetamide based therapies well as the intense competition, among leading companies are contributing factors to market trends. Exploring the factors that drive the market industry in the region includes a focus on top notch treatments and a proactive approach to healthcare. Additionally regular skin care practices play a role, in boosting the Sodium sulfacetamide sector in the region.

North America Outlook

In North America's Sodium sulfacetamide usage leads the way with a growing demand in the skincare and pharmaceutical industries. The skincare and pharmaceutical sectors hold opportunities as Sodium sulfacetamides therapeutic benefits gain recognition for treating skin conditions such as acne and seborrheic dermatitis. Despite this growth potential the market encounters competition, from major players constantly unveiling new products. Key factors driving the market include a growing population focused on skincare and the increased use of medical treatments incorporating Sodium sulfacetamide.

North America Outlook

In North America's Sodium sulfacetamide usage leads the way with a growing demand in the skincare and pharmaceutical industries. The skincare and pharmaceutical sectors hold opportunities as Sodium sulfacetamides therapeutic benefits gain recognition for treating skin conditions such as acne and seborrheic dermatitis. Despite this growth potential the market encounters competition, from major players constantly unveiling new products. Key factors driving the market include a growing population focused on skincare and the increased use of medical treatments incorporating Sodium sulfacetamide.

Europe Outlook

In Europe's dermatological fields Sodium sulfacetamide is set to gain advantages from the significant rise in research activities and applications in the pharmaceutical industry. The emphasis is particularly placed in creating remedies for various skin problems. The growing awareness of cosmetics among customers and the popularity of Sodium sulfacetamide based therapies well as the intense competition, among leading companies are contributing factors to market trends. Exploring the factors that drive the market industry in the region includes a focus on top notch treatments and a proactive approach to healthcare. Additionally regular skin care practices play a role, in boosting the Sodium sulfacetamide sector in the region.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, China, Japan, India are expected to grow at 6.8% to 9.8% CAGR

2

Emerging Markets : Mexico, Indonesia, South Africa are expected to grow at 8.9% to 11.6% CAGR

Market Analysis Chart

In the pharmaceutical industry sodium sulfacetamide is widely. Its growth path is influenced by various factors like market demand and limitations. Being an agent it is increasingly sought after in the medical sector for addressing issues such as acne and seborrheic dermatitis. The rising demand for skincare solutions is elevating its significance thereby playing a major role in driving the market for sodium sulfacetamide. Nonetheless there are also constraints within the market that are crucial, for evaluating its overall growth potential.

Recent Developments and Technological Advancement

November 2024

Pharmaceutical powerhouse PharmGiant unveiled a cutting edge formula based on sodium sulfacetamide that marks an advancement in the treatment of acne and rosacea. This groundbreaking development is poised to reshape the landscape of the skincare industry.

September 2024

The innovative biotech firm Bioscience Labs is pushing the boundaries by exploring possibilities, with sodium sulfacetamide in their exciting clinical trials for a groundbreaking therapy targeting inflammatory eye disorders.

July 2024

MedSynth is a known company worldwide that has started making sodium sulfacetamide in a way that is kinder to the environment. This move not only lowers the environmental footprint of production but also establishes a new benchmark for sustainability, in the industry.

In recent times sodium sulfacetamide has seen a rise in popularity within the health and skincare sector due to its antibacterial properties and effectiveness in tackling skin issues like acne and inflammation fueled by the ongoing trend of opting for pharmaceutical grade ingredients, in personal care routines.

Impact of Industry Transitions on the Sodium Sulfacetamide Market

As a core segment of the Pharmaceutical industry, the Sodium Sulfacetamide market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Personalized Medicine and Incorporation in OvertheCounter Products have redefined priorities across the Pharmaceutical sector, influencing how the Sodium Sulfacetamide market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Shift towards Personalized Medicine:

The field of pharmaceuticals is going through a change towards personalized medicine that focuses on customizing treatment for individuals based on their genetic characteristics. We are seeing a shift in how Sodium Sulfacetamide is being used as a powerful antibacterial treatment for acne within this personalized medicine approach. The dosage and frequency of Sodium Sulfacetamide may see adjustments, in personalized treatment plans. For instance than a standard dosage Sodium Sulfacetamide could be paired with Sulphur or other treatments customized for a persons unique acne prone genetic makeup.

2

Incorporation in OvertheCounter Products:

The industry has seen a shift with the inclusion of Sodium Sulfacetamide in Over The Counter . This change is mainly driven by consumers growing awareness of issues like acne and rosacea and their preference, for self treatment.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Pharmaceutical industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Pharmaceutical industry cascade into the Sodium Sulfacetamide market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Rise in Acne Prevalence

One key factor driving the growth of the Sodium sulfacetamide market is also the rising prevalence of acne. Sodium sulfacetamide is also commonly utilized in treating acne because of its properties. With an increasing number of people experiencing acne globally there is also a growing need for acne remedies leading to a higher demand, for Sodium sulfacetamide.
also Advances in technology within the field of dermatology have also greatly contributed to the increasing demand for Sodium sulfacetamide in the market well. Cutting edge treatments for skin ailments like rosacea and seborrhea dermatitis that prominently feature Sodium sulfacetamide have also opened up avenues for growth in this sector. Ongoing research into topical uses of this compound further emphasizes its potential, for expansion.

Restraint: Regulatory Challenges

In the Sodium sulfacetamide sectors realm of operation lies a persistent hurdle of navigating limitations successfully for its players and stakeholders alike. Companies within this domain must adhere strictly to rigorous regulatory protocols concerning the quality assurance and safety aspects of their products to circumvent any legal entanglements that may arise. Key regulatory bodies such as the FDA and EMA wield control over the entire lifecycle of topical medications incorporating Sodium sulfacetamide due to potential adverse reactions associated with sulfonamides. This intricate and expensive process not only poses challenges but also has the potential to deter investors due, to decreased market attractiveness which could subsequently impede overall market expansion.

Challenge: Side Effect Concerns

The possibility of experiencing side effects is a concern related to Sodium sulfacetamide in the market sector it serves well in terms of safety when used topically; nonetheless there are cases where individuals may encounter allergic responses or skin irritations from its application. This potential issue might cause hesitancy among both consumers and healthcare professionals when considering Sodium sulfacetamide based products. In instances serious hypersensitivity reactions like Stevens Johnson syndrome may arise, raising doubts, about the safety of the product.

Supply Chain Landscape

Raw Material Procurement

Brenntag AG

Tata Chemicals Ltd

Intermediary Manufacturing

Cytec Industries Inc.

Sumitomo Chemical Co

Production
Pfizer Inc. / Sanofi S.A
End User Industry
Medical / Cosmetics / Veterinary Medicine
Raw Material Procurement

Brenntag AG

Tata Chemicals Ltd

Intermediary Manufacturing

Cytec Industries Inc.

Sumitomo Chemical Co

Production

Pfizer Inc.

Sanofi S.A

End User Industry

Medical

Cosmetics

Veterinary Medicine

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Acne Treatment
Pharmaceuticals
Valeant Pharmaceuticals
Expanding product line for acne treatment with sodium sulfacetamide-based solutions
Rosacea Management
Skincare
Bausch Health
Investing in clinical trials and research for effective rosacea management with sodium sulfacetamide
Seborrheic Dermatitis Control
Dermatology
Perrigo Company plc
Strategic product diversification in dermatology, focusing on sodium sulfacetamide formulations
Veterinary Medicine
Animal Care
Zoetis
Applying sodium sulfacetamide for bacterial skin conditions in pets, reinforcing their comprehensive veterinary care approach

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Sodium Sulfacetamide market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Sodium Sulfacetamide in Seborrhoeic Dermatitis Treatment, Rosacea Management and Acne Treatment

Seborrhoeic Dermatitis Treatment

The use of sodium sulfacetamide is important in the treatment of dermatitis due to its strong antifungal and anti inflammatory properties that help manage the symptoms of this skin condition effectively. In general a 10% wash or cream containing sodium sulfacetamide can alleviate itching, reduceness, in redness and scaling on the skin effectively.

Rosacea Management

The ability of sodium sulfacetamide to fight bacteria and reduce inflammation makes it a useful ingredient for treating rosacea symptoms. It is commonly paired with sulfur to manage redness and swelling in rosacea patients. Many doctors recommend a 10% lotion of sodium sulfacetamide to help relieve rosacea symptoms. Dermik Laboratories under the wing of Sanofi has earned a reputation for its sodium sulfacetamide products specially designed for those, with rosacea.

Acne Treatment

The use of sodium sulfacetamide has been widespread in treating acne issues for quite some time. This particular substance is commonly found in a 10% form and is mainly focused on addressing Propiobacterium acnes. The bacteria that worsen acne conditions. By controlling the growth of these bacteria with sodium sulfacetamide such treatments can reduce inflammation and promote clearer skin. Key companies, like Galderma S. A. and Valeant Pharmaceuticals have established themselves as suppliers of acne remedies based on sodium sulfacetamide.

Sodium Sulfacetamide vs. Substitutes:
Performance and Positioning Analysis

Compared to alternatives, Sodium sulfacetamide imparts distinctive antibacterial effects in skin care, offering unique positioning in dermatological solutions. This compounds potential market growth is propelled by increasing skincare awareness. These Alternatives specially Clindamycin Phosphate has experienced a rapid growth as detailed in our latest report.

Sodium Sulfacetamide
  • Sulfur Topical /
  • Clindamycin Phosphate /
  • Benzoyl Peroxide
    Effective anti-bacterial properties, Versatility in treating various skin conditions
    Potential for side-effects such as skin irritation, Not suitable for individuals with sulfa allergies
    Effective in treating a variety of skin conditions, more natural ingredients
    Potential for skin irritation, Higher prices

Sodium Sulfacetamide vs. Substitutes:
Performance and Positioning Analysis

Sodium Sulfacetamide

  • Effective anti-bacterial properties, Versatility in treating various skin conditions
  • Potential for side-effects such as skin irritation, Not suitable for individuals with sulfa allergies

Sulfur Topical / Clindamycin Phosphate / Benzoyl Peroxide

  • Effective in treating a variety of skin conditions, more natural ingredients
  • Potential for skin irritation, Higher prices

Compared to alternatives, Sodium sulfacetamide imparts distinctive antibacterial effects in skin care, offering unique positioning in dermatological solutions. This compounds potential market growth is propelled by increasing skincare awareness. These Alternatives specially Clindamycin Phosphate has experienced a rapid growth as detailed in our latest report.

Loading...

Research Methodology

This market research methodology defines the Sodium Sulfacetamide market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Pharmaceutical ecosystem, we analyze Sodium Sulfacetamide across Acne treatment, Seborrheic dermatitis management, and Blepharitis therapy Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Valeant Pharmaceuticals, Bayer AG, and Taro Pharmaceuticals by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Procurement, Intermediary Manufacturing, and Production. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Pharmaceutical revenues to estimate the Sodium Sulfacetamide segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Procurement (Brenntag AG, Tata Chemicals Ltd), Intermediary Manufacturing (Cytec Industries Inc., Sumitomo Chemical Co), and Production. Our parallel substitute analysis examines Sulfur Topical, Clindamycin Phosphate, and Benzoyl Peroxide, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Valeant Pharmaceuticals, Bayer AG, and Taro Pharmaceuticals, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Sodium Sulfacetamide market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Sodium Sulfacetamide Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 566 million
Revenue Forecast in 2034USD 1.26 billion
Growth RateCAGR of 9.3% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024518 million
Growth OpportunityUSD 742 million
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD million and Industry Statistics
Market Size 2024518 million USD
Market Size 2027676 million USD
Market Size 2029808 million USD
Market Size 2030883 million USD
Market Size 20341.26 billion USD
Market Size 20351.38 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Form, Application, End-Use Industry, Distribution Channel, Regulatory Status
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledValeant Pharmaceuticals, Bayer AG, Taro Pharmaceuticals, Galderma Laboratories, Teva Pharmaceutical Industries, Allergan Plc, Sandoz Inc, Alcon Labs Inc, Bausch Health Companies Inc, PuraCap Pharmaceutical LLC, Novartis International AG and Otsuka Pharmaceutical Co. Ltd
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Sodium Sulfacetamide Market Size, Opportunities & Strategic Insights, by Product Form

4.1Topical suspension
4.2Topical cream
4.3Topical gel
Chapter 5

Sodium Sulfacetamide Market Size, Opportunities & Strategic Insights, by Application

5.1Acne treatment
5.2Seborrheic dermatitis management
5.3Blepharitis therapy
5.4Others
Chapter 6

Sodium Sulfacetamide Market Size, Opportunities & Strategic Insights, by End-Use Industry

6.1Pharmaceutical
6.2Cosmetics
6.3Veterinary
6.4Others
Chapter 7

Sodium Sulfacetamide Market Size, Opportunities & Strategic Insights, by Distribution Channel

7.1Online pharmacies
7.2Drug stores
7.3Hospital pharmacies
Chapter 8

Sodium Sulfacetamide Market Size, Opportunities & Strategic Insights, by Regulatory Status

8.1Prescription-based
8.2Over-the-counter
Chapter 9

Sodium Sulfacetamide Market, by Region

9.1North America Sodium Sulfacetamide Market Size, Opportunities, Key Trends & Strategic Insights
9.1.1U.S.
9.1.2Canada
9.2Europe Sodium Sulfacetamide Market Size, Opportunities, Key Trends & Strategic Insights
9.2.1Germany
9.2.2France
9.2.3UK
9.2.4Italy
9.2.5The Netherlands
9.2.6Rest of EU
9.3Asia Pacific Sodium Sulfacetamide Market Size, Opportunities, Key Trends & Strategic Insights
9.3.1China
9.3.2Japan
9.3.3South Korea
9.3.4India
9.3.5Australia
9.3.6Thailand
9.3.7Rest of APAC
9.4Middle East & Africa Sodium Sulfacetamide Market Size, Opportunities, Key Trends & Strategic Insights
9.4.1Saudi Arabia
9.4.2United Arab Emirates
9.4.3South Africa
9.4.4Rest of MEA
9.5Latin America Sodium Sulfacetamide Market Size, Opportunities, Key Trends & Strategic Insights
9.5.1Brazil
9.5.2Mexico
9.5.3Rest of LA
9.6CIS Sodium Sulfacetamide Market Size, Opportunities, Key Trends & Strategic Insights
9.6.1Russia
9.6.2Rest of CIS
Chapter 10

Competitive Landscape

10.1Competitive Dashboard & Market Share Analysis
10.2Company Profiles (Overview, Financials, Developments, SWOT)
10.2.1Valeant Pharmaceuticals
10.2.2Bayer AG
10.2.3Taro Pharmaceuticals
10.2.4Galderma Laboratories
10.2.5Teva Pharmaceutical Industries
10.2.6Allergan Plc
10.2.7Sandoz Inc
10.2.8Alcon Labs Inc
10.2.9Bausch Health Companies Inc
10.2.10PuraCap Pharmaceutical LLC
10.2.11Novartis International AG
10.2.12Otsuka Pharmaceutical Co. Ltd